A New Risk Score for the Emergency Department in Patients With Upper Gastrointestinal Bleeding

Abstract Background: The aim of this study was to develop a simpler, more practical, and highly effective risk scoring system for patients presenting to the emergency department with upper gastrointestinal bleeding.

Methods: This single-center retrospective observational study was conducted by reviewing data from patients aged 18 years and older who presented to the Emergency Medicine Clinic of Sakarya Training and Research Hospital with symptoms and signs of upper gastrointestinal bleeding between January, 2022 to June, 2023. Patients were divided into six groups for analysis. Patients included in the transfusion, intervention, intense care unit, readmission or mortality groups were classified as high risk. Using the obtained data, a new scoring system was developed, and its effectiveness in predicting high risk and all subgroups was compared with the Glasgow Blatchford Score, AIMS65, and pre-endoscopic Rockall Score.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Upper Gastrointestinal Bleeding (UGIB) Digestive System Diseases Disease Attributes Emergencies Emergency Department Patient Gastrointestinal Diseases Gastrointestinal Hemorrhage Hemorrhage Pathologic Processes Pathological Conditions, Signs and Symptoms Risk Scores

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sakarya Training and Research Hospital

Sakarya, Adapazarı, 54100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients aged over 18 years who presented to the ED with UGIB symptoms and signs (hematemesis, melena, and hematochezia) and were hospitalized between January 1, 2022, and June 1, 2023, were included in the study.

Exclusion criteria

Patients with insufficient data, lower gastrointestinal bleeding, or those who did not undergo endoscopy due to death, refusal of treatment, or symptom resolution were excluded.

Treatment and study plan

Routine laboratory tests of the patients were examined (such as hemogram, biochemistry, bleeding parameters).

Other

Data obtained from routine examinations, laboratory tests and hospital reports were evaluated.

Primary outcomes

Develop a new risk score capable of predicting the high-risk group

Time frame: 1 year

The primary outcome was to develop a new risk score that can predict the high-risk group in the emergency department in patients with upper gastrointestinal bleeding. In the new risk score, high scores were intended to be more associated with high risk.

Sponsors and collaborators

Lead sponsor

Sakarya University

Other

Registry information

Official study title

Comparison of the New Risk Score (ABL Score) With the Glasgow Blatchford Score, AIMS65, and Pre-Endoscopic Rockall Score in Patients With Upper Gastrointestinal Bleeding Admitted to the Emergency Department

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Mar 14, 2025
Registry last updated: Mar 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed